We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+13.23%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$138B
AUM Growth
+$12.8B
(+10%)
Cap. Flow
-$1.91B
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
301
New
8
Increased
70
Reduced
156
Closed
8
Avg Time Held
4.4
years
Top 10 Avg Time Held
4.6
years
Top 20 Avg Time Held
3.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$258M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$88.2M |
| 3 |
Visa
V
|
+$74.2M |
| 4 |
Raymond James Financial
RJF
|
+$72.1M |
| 5 |
LivaNova
LIVN
|
+$70.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$304M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$283M |
| 3 |
Insulet
PODD
|
+$255M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$242M |
| 5 |
Adobe
ADBE
|
+$229M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Healthcare | 26.48% |
| 3 | Industrials | 14.72% |
| 4 | Financials | 10.81% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Five Below
FIVE
$12.3B
| $1.69M | ﹤0.01% |
13,200
| – | – |
2018 Q2
6 quarters
|
|
277
Ingevity
NGVT
$2.43B
| $1.69M | ﹤0.01% |
19,300
-7,400
| -28% | -$647K |
2017 Q4
8 quarters
|
|
|
ASNA
278
DELISTED
Ascena Retail Group, Inc.
ASNA
| $1.68M | ﹤0.01% |
219,650
-80,000
| -27% | -$656K |
2013 Q2
26 quarters
|
|
279
Prestige Consumer Healthcare
PBH
$2.33B
| $1.68M | ﹤0.01% |
41,400
-1,100
| -3% | -$41K |
2017 Q4
8 quarters
|
|
280
Arbutus Biopharma
ABUS
$850M
| $1.67M | ﹤0.01% |
600,000
-3,440,900
| -85% | -$5.57M |
2015 Q1
19 quarters
|
|
281
Adient
ADNT
$1.4B
| $1.56M | ﹤0.01% |
73,520
| – | – |
2016 Q4
12 quarters
|
|
|
CERN
282
DELISTED
Cerner Corp
CERN
| $1.42M | ﹤0.01% |
19,400
| – | – |
2013 Q2
26 quarters
|
|
|
AUD
283
DELISTED
Audacy, Inc.
AUD
| $1.39M | ﹤0.01% |
300,000
-349,822
| -54% | -$1.46M |
2017 Q4
8 quarters
|
|
284
Controladora Vuela Compania de Aviacion
VLRS
$689M
| $1.38M | ﹤0.01% |
132,000
| – | – |
2013 Q4
24 quarters
|
|
285
Celanese
CE
$5.1B
| $1.35M | ﹤0.01% |
10,950
| – | – |
2013 Q2
26 quarters
|
|
286
Acuity Brands
AYI
$9.04B
| $966K | ﹤0.01% |
7,000
| – | – |
2017 Q4
8 quarters
|
|
|
SIOX
287
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $617K | ﹤0.01% |
120,425
-2,862
| -2% | -$15.9K |
2015 Q2
18 quarters
|
|
288
Performance Food Group
PFGC
$15.3B
| $571K | ﹤0.01% |
11,100
| – | – |
2017 Q2
10 quarters
|
|
289
Bloom Energy
BE
$69.6B
| $527K | ﹤0.01% |
70,600
-25,000
| -26% | -$121K |
2019 Q3
1 quarter
|
|
|
HOME
290
DELISTED
At Home Group Inc.
HOME
| $479K | ﹤0.01% |
87,100
| – | – |
2019 Q1
3 quarters
|
|
291
Resideo Technologies
REZI
$2.52B
| $358K | ﹤0.01% |
30,037
-1,941
| -6% | -$22.1K |
2018 Q4
4 quarters
|
|
292
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-45,500
| Closed | -$2.48M | – |
|
293
DELISTED
Comerica
CMA
| – | – |
-43,600
| Closed | -$2.88M | – |
|
294
DELISTED
Spirit AeroSystems
SPR
| – | – |
-164,200
| Closed | -$13.5M | – |
|
295
Zoom
ZM
$28.7B
| – | – |
-3,400
| Closed | -$259K | – |
|
|
PVTL
296
DELISTED
Pivotal Software, Inc.
PVTL
| – | – |
-511,200
| Closed | -$7.63M | – |
|
|
DHXM
297
DELISTED
DHX Media Ltd. Common Voting and Variable Voting Shares
DHXM
| – | – |
-6,450,000
| Closed | -$9.3M | – |
|
Similar funds
Primecap Management's Q4 2019 Portfolio in Review
As of Q4 2019, Primecap Management held 301 positions worth $138B, up 10% from $125B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management's Q4 2019 filing shows 8 new, 70 increased, 156 reduced and 8 closed positions. Its largest new stake was BioNTech: 2,128,182 shares worth $72.1M. The largest sale was Alphabet (Google) Class C, an estimated $304M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2019 buy was BioNTech: 2,128,182 shares worth $72.1M.
- Primecap Management added most to Biogen in Q4 2019, an estimated $258M increase.
- Primecap Management's biggest Q4 2019 reduction was Alphabet (Google) Class C, cutting an estimated $304M.
- Primecap Management fully exited Spirit AeroSystems in Q4 2019, selling an estimated $13.5M.
- Primecap Management's ten largest holdings make up 30% of its $138B portfolio in Q4 2019.
- Primecap Management opened 8 new positions and closed 8 in Q4 2019.
- Primecap Management's portfolio value rose 10% quarter-over-quarter to $138B.
Based on Primecap Management's 13F filing for Q4 2019, filed 14 Feb 2020.